Medical Devices; Gastroenterology-Urology Devices; Classification of the Flushing and Storage Solution for Vascular Autografts at Room Temperature
By Health, Human Services Department, Food, Drug Administration · Sep 29, 2026, 11:00 PM CDT
The Food and Drug Administration (FDA) is classifying the flushing and storage solution for vascular autografts at room temperature into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the flushing and storage solution for vascular autografts at room temperature. We are taki
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisAppeal to AuthorityThe statement relies on the FDA’s authority to lend credibility to the classification decision.
Benefit FramingThe announcement frames the classification as beneficial for patients and industry, emphasizing positive outcomes.
Context
AI analysisMissing context
The announcement does not provide details about the specific special controls that will apply, the criteria used to determine the classification, or how the change will affect manufacturers, clinicians, and patients in practice.
Important context
Class II classification with special controls indicates that the device is considered moderate risk and will be subject to specific regulatory requirements beyond general controls, which can influence market entry, compliance costs, and post‑market surveillance.
Opinion vs. reporting
AI analysisThe text is presented as factual reporting of an FDA regulatory action without editorial commentary or opinion.